Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 9

1.

Plasmon resonance and the imaging of metal-impregnated neurons with the laser scanning confocal microscope.

Thompson KJ, Harley CM, Barthel GM, Sanders MA, Mesce KA.

Elife. 2015 Dec 15;4. pii: e09388. doi: 10.7554/eLife.09388.

3.

The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing.

Werner D, Battmann A, Steinmetz K, Jones T, Lamb T, Martinez M, Altmannsberger HM, Al-Batran SE.

J Transl Med. 2014 Jun 6;12:160. doi: 10.1186/1479-5876-12-160.

4.

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.

Nitta H, Kelly BD, Padilla M, Wick N, Brunhoeber P, Bai I, Singh S, Ranger-Moore J, Bieniarz C, Tsuda H, Grogan TM.

Diagn Pathol. 2012 May 30;7:60. doi: 10.1186/1746-1596-7-60.

5.

Testing for HER2 in Breast Cancer: A Continuing Evolution.

Shah S, Chen B.

Patholog Res Int. 2010 Dec 6;2011:903202. doi: 10.4061/2011/903202.

6.

Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma.

Gruver AM, Peerwani Z, Tubbs RR.

J Clin Pathol. 2010 Mar;63(3):210-9. doi: 10.1136/jcp.2009.062760. Review.

7.

Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis.

Turashvili G, Leung S, Turbin D, Montgomery K, Gilks B, West R, Carrier M, Huntsman D, Aparicio S.

BMC Cancer. 2009 May 29;9:165. doi: 10.1186/1471-2407-9-165.

8.

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization (FISH).

Nitta H, Hauss-Wegrzyniak B, Lehrkamp M, Murillo AE, Gaire F, Farrell M, Walk E, Penault-Llorca F, Kurosumi M, Dietel M, Wang L, Loftus M, Pettay J, Tubbs RR, Grogan TM.

Diagn Pathol. 2008 Oct 22;3:41. doi: 10.1186/1746-1596-3-41.

9.

Delineation of HER2 gene status in breast carcinoma by silver in situ hybridization is reproducible among laboratories and pathologists.

Carbone A, Botti G, Gloghini A, Simone G, Truini M, Curcio MP, Gasparini P, Mangia A, Perin T, Salvi S, Testi A, Verderio P.

J Mol Diagn. 2008 Nov;10(6):527-36. doi: 10.2353/jmoldx.2008.080052. Epub 2008 Oct 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk